Results 281 to 290 of about 102,263 (291)

Meropenem

Drugs, 2012
Katherine A Lyseng-Williamson
exaly  

Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations

Clinical Infectious Diseases, 2019
Jason M Pogue, Robert A Bonomo, Keith S Kaye   +2 more
exaly  

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2017
Mariana Castanheira, Michael D Huband
exaly  

Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2019
Razieh Kebriaei, Mariana Castanheira
exaly  

Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy, 2017
Olga Lomovskaya
exaly  

Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial

Intensive Care Medicine, 2013
Jan J De Waele, Veronique Stove
exaly  

Ultrahigh antibacterial efficacy of meropenem-loaded chitosan nanoparticles in a septic animal model

Carbohydrate Polymers, 2017
Ayat Abdelkader, Mohamed A El-Mokhtar, Mostafa A Hamad   +2 more
exaly  

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

Clinical Infectious Diseases, 2016
exaly  

Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections

Drugs, 2018
exaly  

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial

Journal of Antimicrobial Chemotherapy, 2013
exaly